a public good project by the
Synthesis
Company
of California

© 2026

Andrew G. Brewster | doi.page

0 works0 citations0 h-index

Andrew G. Brewster

GlaxoSmithKline (United Kingdom)(GB)GlaxoSmithKline (France)(FR)

Publications by Year

Research Areas

Asymmetric Synthesis and Catalysis, Chemical Synthesis and Analysis, Synthetic Organic Chemistry Methods, Axial and Atropisomeric Chirality Synthesis, Synthesis and Reactivity of Sulfur-Containing Compounds

Most-Cited Works

→ Substituted 2-[(4-Aminomethyl)phenoxy]-2-methylpropionic Acid PPARα Agonists. 1. Discovery of a Novel Series of Potent HDLc Raising Agents(2007)117 cited
→ Regioselective Dieckmann cyclisations leading to enantiopure highly functionalised tetramic acid derivatives(1998)61 cited
→ Oxidation of alcohols using benzeneseleninic anhydride(1978)58 cited
→ Oxidation of phenols, pyrocatechols, and hydroquinones to ortho-quinones using benzeneseleninic anhydride(1981)51 cited
→ Oxidation of phenols to ortho-quinones using diphenylseleninic anhydride(1976)32 cited
→ The synthesis of a novel thromboxane receptor antagonis 4(Z)-6-(2--chlorophenyl-4--hydroxyphenyl-1,3-dioxan--5-yl) hexenoic acid ICI 192605(1988)30 cited
→

A Novel Approach to Dual-Acting Thromboxane Receptor Antagonist/Synthase Inhibitors Based on the Link of 1,3-Dioxane-Thromboxane Receptor Antagonists and -Thromboxane Synthase Inhibitors

(1995)

29 cited

→ Highly Functionalised Pyroglutamates by Intramolecular Aldol Reactions: Towards the Pyroglutamate Skeleton of Oxazolomycin(1996)26 cited

→ Dual-Acting Thromboxane Receptor Antagonist/Synthase Inhibitors: Synthesis and Biological Properties of [2-Substituted-4-(3-pyridyl)-1,3-dioxan-5-yl]alkenoic Acids(1995)26 cited

→ Memory of chirality effects in aldol cyclisations of 1-(3-oxobutyryl) derivatives of l-4-oxaproline and l-proline isopropyl esters(2002)25 cited